2023 annual financial data
Artiva Biotherapeutics 2023 Operating margin
Direct answer
Operating margin was -91.58%.
Operating income was -30,671,000 USD and net income was -27,696,000 USD.
Operating cash flow was -47,430,000 USD.
Get free Artiva Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,492,000 USD
- Operating income
- -30,671,000 USD
- Net income
- -27,696,000 USD
- Operating cash flow
- -47,430,000 USD